1-161591221-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000466542.6(FCGR2C):c.469G>T(p.Asp157Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000139 in 143,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 6/9 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000466542.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGR2C | NR_047648.1 | n.568G>T | non_coding_transcript_exon_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGR2C | ENST00000466542.6 | c.469G>T | p.Asp157Tyr | missense_variant | 4/7 | 1 | ENSP00000426627.1 | |||
ENSG00000289768 | ENST00000699402.1 | c.40+39834C>A | intron_variant | ENSP00000514363.1 |
Frequencies
GnomAD3 genomes AF: 0.0000139 AC: 2AN: 143676Hom.: 0 Cov.: 28
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000281 AC: 4AN: 1421396Hom.: 0 Cov.: 32 AF XY: 0.00000142 AC XY: 1AN XY: 706344
GnomAD4 genome AF: 0.0000139 AC: 2AN: 143794Hom.: 0 Cov.: 28 AF XY: 0.0000286 AC XY: 2AN XY: 69882
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.469G>T (p.D157Y) alteration is located in exon 4 (coding exon 4) of the FCGR2C gene. This alteration results from a G to T substitution at nucleotide position 469, causing the aspartic acid (D) at amino acid position 157 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.